UPDATE: Barclays Upgrades CBL & Associates (CBL) to Overweight; Regional Malls Should See Better Growth

(Updated - July 23, 2012 2:31 PM EDT)

Barclays upgraded CBL & Associates (NYSE: CBL) from Equalweight to Overweight, price target raised from $21 to $22.

Analyst, Ross L. Smotrich, said, "We believe CBL is positioned to outperform its peers
largely due to its favorable lease roll, national platform and outsized dividend yield
(4.6% vs. a REIT average of 3.6%)."

FY12 FFO raised from $2.07 to $2.08, FY13 from $2.15 to $2.19

For an analyst ratings summary and ratings history on CBL & Associates click here. For more ratings news on CBL & Associates click here.

Shares of CBL & Associates closed at $19.04 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• KP Tissue Inc. (KPT:CN) (KPTSF) PT Raised to Cdn$13.50 at Desjardins
• CAE Inc. (CAE:CN) (CAE) PT Raised to Cdn$49 at Desjardins